Strategic Diagnostics Inc. (SDIX)
-NasdaqGM 1.02 
0.01(0.99%) 3:45PM EDT - Nasdaq Real Time Price
| Prev Close: | 1.01 |
|---|
| Open: | 1.02 |
|---|
| Bid: | 1.01 x 7300 |
|---|
| Ask: | 1.05 x 2300 |
|---|
| 1y Target Est: | 4.97 |
|---|
| Beta: | 0.24 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 1.01 - 1.06 |
|---|
| 52wk Range: | 0.87 - 1.85 |
|---|
| Volume: | 4,707 |
|---|
| Avg Vol (3m): | 37,427 |
|---|
| Market Cap: | 21.59M |
|---|
| P/E (ttm): | 4.79 |
|---|
| EPS (ttm): | 0.21 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- STRATEGIC DIAGNOSTICS INC/DE/ FinancialsEDGAR Online Financials(Tue, May 21)
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 15)
- Egalet Appoints Stan Musial as CFOPR Newswire(Wed, May 8)
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 10-K, Annual ReportEDGAR Online(Mon, Apr 15)
- China Biotech In Review: Lilly Invests $100 Million In China Animal Healthcareat Seeking Alpha(Sun, Apr 14)
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors orEDGAR Online(Wed, Apr 10)
- OriGene to Acquire SDIX's Life Science Business AssetsPR Newswire(Mon, Apr 8)
- SDIX Sells Life Science Assets to OriGene Technologies, Inc. for $16 MillionBusiness Wire(Mon, Apr 8)
- SDIX trading halted, pending newstheflyonthewall.com(Mon, Apr 8)
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 8-K, Termination of a Material Definitive AgreementEDGAR Online(Wed, Nov 28)
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, Nov 14)
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online(Tue, Nov 13)
- SDIX Reports Third Quarter 2012 ResultsBusiness Wire(Mon, Nov 12)
- SDIX to Report Third Quarter 2012 Results on November 12, 2012Business Wire(Mon, Nov 5)
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial StaEDGAR Online(Tue, Oct 23)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.42 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Strategic Diagnostics Inc., a biotechnology company, develops, commercializes, and markets proprietary products, services, and solutions for human health and wellness in the United States and internationally.
View More